BILL · 2017–18 SESSION

SB 5401: Rx drug cost transparency

Addressing prescription drug cost transparency.

Summary

  • Requires the office of financial management to use a competitive procurement process to select a data organization to collect, verify, and summarize the prescription drug pricing data provided by issuers and manufacturers. Requires an issuer to submit certain prescription drug cost and utilization data to the data organization for the previous calendar year.

From the Bill Digest (SB 5401), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 23, 2017
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Senator (R-18)
Introduced
January 23, 2017 in the Senate
Last action
January 8, 2018
Companion bill
HB 1541

AN ACT Relating to prescription drug cost transparency;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. Due to Senate committee reorganization, referred to Health & Long Term Care.
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status.
  4. By resolution, reintroduced and retained in present status.
  5. By resolution, reintroduced and retained in present status.
  6. First reading, referred to Health Care.

SB 5401 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page